Posts

Ono Pharmaceutical partners with EME for antibody drug ...

Ono Pharmaceutical has partnered with EME to advance the drug discovery of VHH a...

Telehealth abortion is an “effective, safe” tool for eq...

US patients are travelling to avoid abortion bans, but a new study has found tel...

Charles River and Wheeler Bio partner on therapeutic di...

Charles River has entered into a partnership with Wheeler Bio to expedite the pr...

FDA accepts Regeneron’s BLA for linvoseltamab for review

The FDA has accepted Regeneron’s biologics licence application (BLA) for linvose...

Digital transformation of the supply chain will make da...

One common factor can help make supply chains more comprehensible, resilient and...

Immunocore and BMS partner to investigate first-line tr...

The company will evaluate an IMC-F106C/Opdivo combination treatment in a Phase I...

Harmony wins orphan drug tag for pitolisant to treat Pr...

Harmony is advancing pitolisant into a Phase III clinical trial that is expected...

Immune-Onc’s antibody therapy collects second FDA orpha...

The company’s monoclonal antibody therapy, IO-202, has received its second orpha...

United Therapeutics sues FDA over handling of Liquidia’...

United has commenced litigation with the FDA to combat Liquidia’s Yutrepia encro...

STAT+: Hospitals race to adopt generative AI, even as r...

Large hospitals are experimenting with generative AI at a time when there are no...

STAT+: Ring Therapeutics, a Flagship gene therapy start...

Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has l...

Should ACA plans cover weight loss drugs?

Drug makers are doing everything to tap the bottomless well of demand for new ob...

Medicare Advantage’s 33 million club

Seniors are still flocking to Medicare Advantage even if some insurers fell shor...

STAT+: FDA warns medical device makers about rise in fa...

An increasing number of medical device companies are submitting fabricated and u...

STAT+: AbbVie CEO Gonzalez to step down after a decade ...

AbbVie CEO Richard Gonzalez has been a subject of nearly constant criticism, but...

Bayer, short on cash, reaches into shareholders’ pockets

German pharmaceutical giant Bayer is slashing its dividend by 95%, part of an on...